Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that women with female pattern hair loss had higher waist circumference, triglyceride levels, lower HDL, and blood glucose levels compared to those without hair loss.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Early screening for Metabolic Syndrome in hair loss patients can help prevent heart disease.

Early hair loss in young men is linked to higher risk of metabolic syndrome.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Fat cells help recruit healing cells and build skin structure during wound healing.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Finasteride safely lowers DHT levels without affecting testosterone.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

Fat cells are important for tissue repair and stem cell support in various body parts.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Female hair loss linked to metabolic syndrome, not in males.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Bald men may have higher heart disease risk.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.